Literature DB >> 4607867

Route of administration and drug disposition.

M Gibaldi, D Perrier.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4607867     DOI: 10.3109/03602537408993742

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  7 in total

Review 1.  Hepatic first-pass metabolism in liver disease.

Authors:  T F Blaschke; P C Rubin
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

2.  Drug metabolite concentration-time profiles: influence of route of drug administration.

Authors:  J B Houston; G Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

3.  Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole.

Authors:  Nicolas Hohmann; Franziska Kocheise; Alexandra Carls; Jürgen Burhenne; Johanna Weiss; Walter E Haefeli; Gerd Mikus
Journal:  Clin Pharmacokinet       Date:  2016-12       Impact factor: 6.447

4.  Influence of time and mode of exposure on biotransformation of naphthalene by juvenile starry flounder (Platichthys stellatus) and rock sole (Lepidopsetta bilineata).

Authors:  U Varanasi; D J Gmur; P A Treseler
Journal:  Arch Environ Contam Toxicol       Date:  1979       Impact factor: 2.804

Review 5.  Pharmacokinetics in patients with cardiac failure.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

6.  Studies in pharmacokinetics and tolerance of substances temporarily retained in the liver by microsphere embolization.

Authors:  B Lindell; K F Aronsen; B Nosslin; U Rothman
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969

7.  Protective properties of 2-acetylcyclopentanone in a mouse model of acetaminophen hepatotoxicity.

Authors:  Lihai Zhang; Terrence Gavin; Brian C Geohagen; Qiang Liu; Katherine J Downey; Richard M LoPachin
Journal:  J Pharmacol Exp Ther       Date:  2013-06-12       Impact factor: 4.030

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.